UBC Medical Indonesia (IDX:LABS) - Stock Price, News & Analysis

LABS Stock Overview

Distributes medical devices in Indonesia. More details

LABS fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Rewards

Revenue grew by 46.5% over the past year

Risk Analysis

Interest payments are not well covered by earnings

High level of non-cash earnings

Profit margins (1.6%) are lower than last year (3%)

Does not have a meaningful market cap (IDR514B)

PT UBC Medical Indonesia Tbk Competitors

PT. Penta Valent

IDX:PEVE

Rp430.8b

Itama Ranoraya

IDX:IRRA

Rp639.3b

Dosni Roha Indonesia

IDX:ZBRA

Rp198.3b

Millennium Pharmacon International

IDX:SDPC

Rp207.7b

Price History & Performance

Summary of all time highs, changes and price drops for UBC Medical Indonesia
Historical stock prices
Current Share Price	Rp129.00
52 Week High	Rp228.00
52 Week Low	Rp109.00
Beta	0
11 Month Change	-12.24%
3 Month Change	-6.52%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-5.84%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	LABS	ID Healthcare	ID Market
7D	-3.7%	-3.1%	-2.2%
1Y	n/a	19.3%	9.3%

Return vs Industry: Insufficient data to determine how LABS performed against the ID Healthcare industry.

Return vs Market: Insufficient data to determine how LABS performed against the ID Market.

Price Volatility

Is LABS's price volatile compared to industry and market?
LABS volatility
LABS Average Weekly Movement	4.6%
Healthcare Industry Average Movement	5.8%
Market Average Movement	5.5%
10% most volatile stocks in ID Market	12.6%
10% least volatile stocks in ID Market	2.4%

Stable Share Price: LABS has not had significant price volatility in the past 3 months compared to the ID market.

Volatility Over Time: Insufficient data to determine LABS's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2014	64	Franciscus Yoshua Raintjung	www.ubcindonesia.com

PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. It operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. The company offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products.

PT UBC Medical Indonesia Tbk Fundamentals Summary

How do UBC Medical Indonesia's earnings and revenue compare to its market cap?
LABS fundamental statistics
Market cap	Rp513.50b
Earnings (TTM)	Rp2.19b
Revenue (TTM)	Rp136.70b

232.7x

P/E Ratio

3.7x

P/S Ratio

Is LABS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LABS income statement (TTM)
Revenue	Rp136.70b
Cost of Revenue	Rp82.14b
Gross Profit	Rp54.56b
Other Expenses	Rp52.37b
Earnings	Rp2.19b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	0.55
Gross Margin	39.92%
Net Profit Margin	1.60%
Debt/Equity Ratio	82.8%

How did LABS perform over the long term?

See historical performance and comparison